Dr. Wiestner on novel therapies and me on my l... - CLL Support

CLL Support

22,325 members38,394 posts

Dr. Wiestner on novel therapies and me on my lingering cold

bkoffman profile image
bkoffmanCLL CURE Hero
2 Replies

Friends

Our very thin CLL Society team (me, my wife, and a wonderful part time RN) is busy preparing for the ASCO (American Society of Clinical Oncology) 2015 Annual meeting which starts at the end of this week in Chicago, but we still found time to bring three diverse and instructive new topics to our website cllsociety.org for this week.

Today, we posted Dr. Adrian Wiestner's (the leading CLL researcher at the NIH) thoughtful and well-considered interview from ASH (American Society of Hematology) 2014 on what is known and unknown about novel therapies. You can find that under the convention coverage section of the website.

Expect more video interviews and commentaries from ASH 2014 over the next several weeks.

If you want a preview of the other topics to be posted later this week, or just want to read my meandering and worries about how I deal (or don’t deal) with my lingering head cold, please check out today’s blog post: bkoffman.blogspot.com

Does everybody with CLL worry when they get a simple cold that it will devolve into a fulminant pneumonia? I admit I do.

Stay strong.

We are all in this together.

Brian

cllsociety.org

bkoffman.blogspot.com

Written by
bkoffman profile image
bkoffman
CLL CURE Hero
To view profiles and participate in discussions please or .
Read more about...
2 Replies
SBMACLL profile image
SBMACLL

Brian,

Thanks for posting Dr. Wiestner's interview.

Steve

PaulaS profile image
PaulaSVolunteer

I agree wholeheartedly with Steve. It's a very helpful and relevant interview with Dr Wiestner. Thanks Brian.

Paula

You may also like...

ASH 2016: Dr. Seymour on Combination therapies with venetoclax

therapies for CLL. This week I'm posting an interview on our nonprofit’s website...

My 1 year CAR-T anniversary and from ASH 2018, Dr. Siddiqi on how CLL treatment has changed.

ersary/ Also this week, I posted a brief ASH 2018 interview with Dr. Siddiqi that hits the important

Starting CAR-T therapy for my relapsing CLL

this together. Brian Koffman http://cllsociety.org http://bkoffman.blogspot.com

ASH 2015: Dr. John M Pagel on the Problems with Idelalisib as Frontline Therapy in CLL

while since I posted an interview on my blog first instead of the CLL Society website, but I thought

Off ibrutinib x 2 weeks, a novel ultra low dose triple therapy for CLL and Richter's and CLL Society recognized for its reliable robust info

recognizing the CLL Society as a reliable and robust source of information. See:...